Foot ulcers can result from factors like high blood sugar, poor circulation, neuropathy and foot abnormalities.” He cautioned ...

Objective We examined associations between ulcer bioburden and ulcer outcomes in neuropathic diabetic foot ulcers (DFUs) that lacked clinical signs of infection. Research Design and Methods Three ...

Investigations. Radiographs of the foot. Diagnosis. Diabetic Charcot arthropathy with rocker bottom deformity and plantar midfoot ulcer. Management. The ulcer was initially treated by debridement ...

Amesanar is under clinical development by RHEACELL and currently in Phase II for Diabetic Foot Ulcers. According to GlobalData, Phase II drugs for Diabetic Foot Ulcers does not have sufficient ...

All diabetic individuals are at risk of developing these ulcers. The onset of these ulcers are different ranging from cuts especially during toe nail clipping, pressure on the foot from footwear ...

Now, her company, Siren, has secured $9.5 million, with an $8 million check from lead investor Mölnlycke Health Care to further the development and adoption of its diabetic foot ulcer (DFU ...

Health Minister Dr. Shane Reti has unveiled a new qualification aimed at enhancing foot care training, benefiting individuals ...

RION, a clinical-stage regenerative medicine company at the forefront of exosome-based therapeutics, announced today that it has completed patient enrollment in its Phase 2 clinical trial for Purified ...

Most diabetic wound care products are passive dressings, only providing a protective barrier against the external environment ...

ENERGIF-703 is under clinical development by Energenesis Biomedical and currently in Phase III for Diabetic Foot Ulcers.